Actuate Therapeutics, Inc. (ACTU)
0.9812
-0.01
(-1.41%)
USD |
NASDAQ |
Sep 18, 16:00
0.98
0.00 (0.00%)
After-Hours: 05:29
Actuate Therapeutics Price : 0.9812 for Sept. 18, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | 1.00 | 1.03 | 0.9601 | 0.9812 | 114377.0 |
| Sep 17, 2026 | 1.04 | 1.050 | 0.9625 | 0.9952 | 174596.0 |
| Sep 16, 2026 | 1.00 | 1.05 | 0.94 | 0.9974 | 208826.0 |
| Sep 15, 2026 | 1.04 | 1.06 | 0.98 | 0.9837 | 148446.0 |
| Sep 14, 2026 | 1.08 | 1.090 | 0.99 | 1.03 | 259021.0 |
| Sep 11, 2026 | 1.15 | 1.230 | 1.03 | 1.07 | 239601.0 |
| Sep 10, 2026 | 1.25 | 1.28 | 1.13 | 1.15 | 204996.0 |
| Sep 09, 2026 | 1.38 | 1.400 | 1.26 | 1.26 | 124416.0 |
| Sep 08, 2026 | 1.46 | 1.48 | 1.330 | 1.37 | 210022.0 |
| Sep 04, 2026 | 1.45 | 1.73 | 1.33 | 1.48 | 1.323M |
| Sep 03, 2026 | 1.39 | 1.46 | 1.26 | 1.37 | 474036.0 |
| Sep 02, 2026 | 1.50 | 1.55 | 1.30 | 1.30 | 335528.0 |
| Sep 01, 2026 | 1.49 | 1.58 | 1.410 | 1.54 | 129763.0 |
| Aug 31, 2026 | 1.64 | 1.65 | 1.46 | 1.52 | 274736.0 |
| Aug 28, 2026 | 1.69 | 1.780 | 1.630 | 1.655 | 231304.0 |
| Aug 27, 2026 | 1.77 | 1.796 | 1.63 | 1.69 | 366078.0 |
| Aug 26, 2026 | 1.73 | 1.97 | 1.57 | 1.78 | 3.304M |
| Aug 25, 2026 | 1.24 | 1.58 | 1.200 | 1.58 | 589188.0 |
| Aug 24, 2026 | 1.28 | 1.310 | 1.180 | 1.23 | 179285.0 |
| Aug 21, 2026 | 1.22 | 1.342 | 1.18 | 1.27 | 275824.0 |
| Aug 20, 2026 | 1.06 | 1.34 | 1.010 | 1.23 | 938987.0 |
| Aug 19, 2026 | 1.04 | 1.10 | 1.00 | 1.06 | 156643.0 |
| Aug 18, 2026 | 1.00 | 1.14 | 0.9889 | 1.05 | 327909.0 |
| Aug 17, 2026 | 1.02 | 1.03 | 0.95 | 0.99 | 130433.0 |
| Aug 14, 2026 | 0.966 | 1.03 | 0.90 | 1.01 | 109727.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.29 |
| Alnylam Pharmaceuticals, Inc. | 239.56 |
| Anika Therapeutics, Inc. | 20.81 |
| Savara, Inc. | 5.37 |
| Vericel Corp. | 40.02 |
Price Related Metrics
| Price to Book Value | 23.82 |
| Earnings Yield | -90.86% |
| Market Cap | 23.56M |